Pfizer drug found with serious side effect

Nov 01, 2006

U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Pfizer says the trials involving what is viewed as the company's most important pending drug confirm its increases blood pressure, The New York Times reported.

Analysts say Pfizer, the world's largest drug company. Expects torcetrapib to replace the $13 billion in annual sales from the cholesterol-lowering drug Lipitor, which loses patent protection in 2010.

Pfizer's stock dropped 2 percent after the Tuesday announcement by the company, which has been researching torcetrapib for a decade and is spending $800 million to develop it, the Times said.

Pfizer said it still expects to submit the medicine for federal approval sometime during the second half of next year, with an approval possible in 2008.

Pfizer hopes to show a combination of torcetrapib and Lipitor can reduce the formation of arterial plaque.

Copyright 2006 by United Press International

Explore further: First newborn screening test approved for rare immune disorder

add to favorites email to friend print save as pdf

Related Stories

Research shows Jaws didn't kill his cousin

39 minutes ago

New research suggests our jawed ancestors weren't responsible for the demise of their jawless cousins as had been assumed. Instead Dr Robert Sansom from The University of Manchester believes rising sea levels ...

Microbiome may have shaped early human populations

2 hours ago

We humans have an exceptional age structure compared to other animals: Our children remain dependent on their parents for an unusually long period and our elderly live an extremely long time after they have ...

Recommended for you

New system targets germs in donated blood plasma

14 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.